Drug Interactions Database

3916 interactions from BNF 85 - Check your medicines

Source: BNF 85
leflunomide tucatinib

increases exposure

Unknown Theoretical
leflunomide venetoclax

increases exposure

Unknown Theoretical
leflunomide zidovudine

increases exposure

Unknown Theoretical
letermovir abemaciclib

increases exposure

Unknown Study
letermovir acalabrutinib

increases exposure

Unknown Study
letermovir alphablockers

increases exposure

Unknown Theoretical
letermovir alprazolam

increases exposure

Unknown Study
letermovir amiodarone

increases concentration

Unknown Theoretical
letermovir antiarrhythmics

increases concentration

Unknown Theoretical
letermovir antiepileptics

decreases concentration

Unknown Theoretical
letermovir antifungals,azoles

decreases exposure

Unknown Study
letermovir antihistamines,non-sedating

increases concentration

Unknown Theoretical
letermovir antihistamines,non-sedating

increases exposure

Unknown Theoretical
letermovir antimalarials

increases concentration

Unknown Theoretical
letermovir atorvastatin

increases exposure

Unknown Study
letermovir avanafil

increases exposure

Unknown Theoretical
letermovir avapritinib

increases exposure

Unknown Study
letermovir axitinib

increases exposure

Unknown Study
letermovir bedaquiline

increases exposure

Unknown Theoretical
letermovir benzodiazepines

increases exposure

Unknown Study
letermovir bosentan

increases concentration

Unknown Theoretical
letermovir brigatinib

increases exposure

Unknown Study
letermovir bromocriptine

increases exposure

Unknown Theoretical
letermovir cabazitaxel

increases exposure

Unknown Theoretical
letermovir cabozantinib

increases exposure

Unknown Study
letermovir cariprazine

increases exposure

Unknown Study
letermovir ceritinib

increases exposure

Unknown Study
letermovir cobimetinib

increases exposure

Unknown Study
letermovir colchicine

increases exposure

Unknown Study
letermovir crizotinib

increases exposure

Unknown Study
letermovir dabrafenib

increases exposure

Unknown Study
letermovir dapoxetine

increases exposure

Unknown Theoretical
letermovir darifenacin

increases exposure

Unknown Study
letermovir dasatinib

increases exposure

Unknown Study
letermovir dienogest

increases exposure

Unknown Study
letermovir dipeptidylpeptidase-

increases exposure

Unknown Study
letermovir docetaxel

increases exposure

Unknown Study
letermovir dopaminereceptoragonists

increases exposure

Unknown Theoretical
letermovir drospirenone

increases exposure

Unknown Study
letermovir dutasteride

increases exposure

Unknown Study
letermovir elexacaftor

increases exposure

Unknown Theoretical
letermovir encorafenib

increases exposure

Unknown Study
letermovir endothelinreceptorantagonists

increases concentration

Unknown Theoretical
letermovir endothelinreceptorantagonists

increases exposure

Unknown
letermovir entrectinib

increases exposure

Unknown Theoretical
letermovir eplerenone

increases exposure

Unknown Study
letermovir erlotinib

increases exposure

Unknown Study
letermovir fesoterodine

increases exposure

Unknown Study
letermovir fexofenadine

increases concentration

Unknown Theoretical
letermovir finerenone

increases exposure

Unknown Study
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.